Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-11-20
1993-06-15
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 2622, A61K 3170
Patent
active
052198413
ABSTRACT:
The present invention relates to a pharmaceutical composition for treating a heart disease which comprises a therapeutically effective amount of diadenosine 5',5'"-P.sup.1, P.sup.4 -tetraphosphate as an active ingredient in admixture with a pharmaceutically acceptable carrier or diluent. The pharmaceutical composition is particularly characterized by having antiarrhythmic and coronary vasodilative activities. The present invention also relates to a method for treating a subject having a heart disease or particularly arrhythmia, which comprises administering to the subject an effective amount of the pharmaceutical composition.
REFERENCES:
patent: 3321463 (1967-05-01), Moffatt
Busse et al., "Vasomotor Activity of Diadenosine Triphosphate and Diadenosine Tetraphosphate in Isolated Arteries," Am. J. Physiol., 254(5), H828-H832 (1988).
Nees, "Coronary Flow Increases Induced by Adenosine and Adenine Nucleotides Are Mediated by the Coronoray Endothelium: A New Principle of the Regulation of Coronary Flow," European Heart J., 10, Supplement F, 28-35 (1989).
"Martindale, The Extra Pharmacopoeia, 29th Ed.," Reynolds et al. eds., The Pharmaceutical Press, London, 1989, at p. 1492, see entires for AMP (#9201-m) and ATP (#9203-v).
Luthje, J., Klinisch Wochen-schrift 67:317-327 (1989).
Luthje et al., Biochem. Biophys. Res. Comm, 118(3), 704-709 (1984).
Luthje et al., Eur. J. Biochem., 149, 119-127 (1985).
Blackburn et al., Nucleic Acids Research, 15(17), 6991-7004 (1987).
Harrison et al., FEBS Letters, 54(1), 57-60 (1975).
Elmaleh et al., Proc. Natl. Acad. Sci. USA, 81, 918-921 (1984).
"Metabolism of Diadenosine Tetraphosphate (Ap.sub.4 A)," Conference Abstracts published in Hoppe-Seyler's Z. Physiol. Chem., 365, S597-611 (1984).
Guranowski et al., Biochemistry, 26, 3425-3429 (1987).
Feldhaus et al., Chem. Abstr., 83: 159,849u (1975); see also Eur. J. Biochem., 57(1), 197-204 (1975).
Taurosva et al., Chem. Abstr., 105: 227,203e (1986); see also Bioorg. Khim., 12(3), 404-407 (1986).
Fukunaga et al., Anesthesia and Analgesia, 61, 273-278 (1982).
Inaba Niro
Okamura Kunihiro
Yamaura Tetsuaki
Brown Johnnie R.
Conlin David G.
Crane L. Eric
Eisenstein Ronald I.
Fujirebio Inc.
LandOfFree
Treatment of arrhythmia by administration of Ap.sub.4 A does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of arrhythmia by administration of Ap.sub.4 A, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of arrhythmia by administration of Ap.sub.4 A will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1042773